Celestica Inc. filings document operating results, governance actions, capital-structure matters, and shareholder communications for a Canadian issuer with common shares registered under CLS on the New York Stock Exchange.
Recent disclosures include Form 8-K reports for quarterly and annual financial results, Regulation FD communications, board and committee transitions, annual meeting records, material-event reporting, and share repurchase authorization. The definitive proxy statement covers director elections, executive compensation, shareholder voting procedures, governance policies, and related proxy matters for Celestica’s public-company oversight.
CELESTICA INC Chief Executive Officer Robert Mionis reported multiple indirect sales of common shares on August 13, 2026. A total of 23,496 common shares were sold by an entity identified as “Mionis 2026 GRAT Number Two” at weighted average prices ranging from $360.00 to $365.39 per share, in open-market or private transactions effected pursuant to a Rule 10b5-1 plan adopted on March 11, 2026. Following these transactions, Mionis is reported as holding 453,697 common shares directly and 210,445 common shares indirectly through “Mionis 2026 GRAT Number One.”
MIONIS ROBERT reported acquisition or exercise transactions in this Form 4 filing.
CELESTICA INC Chief Executive Officer Robert Mionis received an equity award of restricted share units. On August 11, 2026, he was granted 1,271 restricted share units (RSUs), each representing a contingent right to receive one common share or an equivalent value in cash. These RSUs vest on April 1, 2029, and following the grant he holds 1,271 RSUs directly.
Reeder David reported acquisition or exercise transactions in this Form 4 filing.
CELESTICA INC director David Reeder reported an equity compensation grant of 133 Director Restricted Share Units (D-RSUs) on August 11, 2026. Each D-RSU represents a contingent right to receive one common share or an equivalent cash value upon settlement, and the granted D-RSUs vest on May 20, 2027. Following this award, Reeder holds 700 D-RSUs directly.
Colpitts Christopher W. reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Christopher W. Colpitts received an equity-based compensation award in the form of 190 Director Restricted Share Units (D-RSUs) on August 11, 2026. Each D-RSU represents a contingent right to receive one common share or equivalent cash value, subject to any deferral election. These 190 D-RSUs vest on May 20, 2027, bringing Colpitts’ directly held D-RSU balance to 1,000 units after the grant.
Maletira Amar reported acquisition or exercise transactions in this Form 4 filing.
CELESTICA INC reported that director Amar Maletira received a grant of 142 Director Restricted Share Units (D-RSUs) on August 11, 2026. Each D-RSU represents a contingent right to receive one common share or an equivalent cash value upon settlement, subject to any deferral election. These D-RSUs vest on May 20, 2027, bringing Maletira’s directly held D-RSU balance to 781 units following this grant.
KOELLNER LAURETTE T reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc director Laurette T. Koellner received an equity award of 317 Director Restricted Share Units (D‑RSUs) on August 11, 2026. Each D‑RSU is a contingent right to receive one common share upon settlement, subject to any deferral election, or, at Celestica’s election, an equivalent value in cash. These 317 D‑RSUs vest on May 20, 2027, bringing Koellner’s directly held D‑RSU balance to 1,127 units following the grant.
Kale Jill reported acquisition or exercise transactions in this Form 4 filing.
CELESTICA INC director Jill Kale received an equity-based compensation grant of 190 Director Restricted Share Units (D‑RSUs) on August 11, 2026. Each D‑RSU represents a contingent right to receive one common share or, at the company’s election, an equivalent cash amount. Following this award, Kale holds 1,000 D‑RSUs, which vest on May 20, 2027, subject to her deferral election.
Colpron Francoise reported acquisition or exercise transactions in this Form 4 filing.
CELESTICA INC director Francoise Colpron received a grant of 203 Director Restricted Share Units (D‑RSUs) on August 11, 2026. Each D‑RSU represents a contingent right to receive one common share upon settlement, or at the issuer’s election an equivalent value in cash. These D‑RSUs vest on May 20, 2027. Following this award, Colpron holds a total of 1,072 D‑RSUs directly.
CASCELLA ROBERT reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Robert Cascella reported an equity compensation grant of 142 Director Restricted Share Units (D‑RSUs) on August 11, 2026. Each D‑RSU represents a contingent right to receive one common share or equivalent cash value upon settlement. These D‑RSUs vest on May 20, 2027, bringing Cascella’s directly held D‑RSUs to 761 units following the award.
Ahuja Kulvinder reported acquisition or exercise transactions in this Form 4 filing.
CELESTICA INC director Kulvinder Ahuja received an equity grant. On August 11, 2026, Ahuja was granted 133 Director Restricted Share Units (D‑RSUs), each representing a contingent right to receive one common share or an equivalent cash value at the issuer’s election. These D‑RSUs vest on May 20, 2027, and Ahuja now holds 700 D‑RSUs in total on a direct basis.